Qube Research & Technologies (QRT)
IMMX icon

Qube Research & Technologies (QRT)’s Immix Biopharma IMMX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.71M Buy
187,675
+137,861
+277% +$1.01M ﹤0.01% 2256
2025
Q4 		$261K Buy
+49,814
New +$205K ﹤0.01% 2995
2024
Q2 		– Sell
-1,243
Closed -$3.82K – 4250
2024
Q1 		$3.82K Buy
+1,243
New +$4.81K ﹤0.01% 3924

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IMMX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Immix Biopharma (IMMX) stake by 277% in Q1 2026, buying an estimated $1.01M and bringing the position to 187,675 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

Qube Research & Technologies (QRT) first reported a position in IMMX in Q1 2024 and has held it in 3 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 187,675 shares of Immix Biopharma worth $1.71M as of Q1 2026.
  • Qube Research & Technologies (QRT) bought 137,861 Immix Biopharma shares in Q1 2026, an estimated $1.01M.
  • Immix Biopharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2256 holding.
  • Qube Research & Technologies (QRT) first reported a position in Immix Biopharma in Q1 2024 and has held it in 3 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.